RDB Jaquiss Duke University

Slides:



Advertisements
Similar presentations
Advance Heart Failure Therapy
Advertisements

Research By: Dr. Ritta Baena Visual Effects By: John Baena
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Congestive Heart Failure
Can Comparative Effectiveness Study Tell Us What Is The Best Therapy For Class IV Heart Failure? Beta blockers or LVADs?
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Stenosis.
Congenital Heart Disease: Outcome in Patients with Single Ventricle
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
Topics Zoll LifeVest  What it is  Who it treats  How does EMS handle these patients?
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Left Ventricular Assist Devices: The What and the Who Lance E. Sullenberger MD FACC FACP Capital Cardiology Associates.
The Cardiac Cycle. Learning Outcomes During diastole blood returning to the atria flows into the ventricles. Atrial systole transfers the remainder of.
HEART TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
Heart Transplantation for Patients with a Fontan Procedure
Joseph G. Rogers, MD Professor of Medicine Duke University
SSA Hearing on Compassionate Allowances Janet N Scheel MD November 9,2010.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Biventricular Failure – Total Artificial Heart Francisco A. Arabía, MD Director, CHSI Center for Surgical Device Management Cedars-Sinai Heart Institute.
Keith Aaronson, Mark Slaughter, Edwin McGee, William Cotts, Michael Acker, Mariell Jessup, Igor Gregoric, Pranav Loyalka, Valluvan Jeevanandam, Allen Anderson,
CARDIAC AND VASCULAR FUNCTION CURVES.. Figure Length-force relationships in intact heart: a Frank-Starling curve Optimal Length.
BWGHF Liège Heart transplantation 2008.
Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Assessment.
HEART TRANSPLANTATION Pediatric Recipients JHLT Oct; 32(10):
HeartWare HVAD: Risk Factors for Adverse Outcomes Mark S. Slaughter, MD Professor and Chair Department Cardiovascular and Thoracic Surgery University of.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
MCS in Special Populations: The Use of Mechanical Support in Adults with Congenital Heart Disease 9 th Annual Meeting May 15, 2015 Christina VanderPluym,MD.
One & A Half Ventricle Repair
Bidirectional Cavo-pulmonary Anastomosis Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Survival following VAD complications: implications for transplant priority. Todd Dardas, MD, MS May 16, 2015.
Update on Pediatric Cardiac Transplantation Dr Jameel Al-ata Consultant & Assistant Professor of Pediatrics & Pediatric Cardiology Taif April 2007.
Fontan Procedure Ken Jusko, DO. Case 39 yo female with h/o tricuspid atresia and A. fib. and prior Fontan. No prior studies available for comparison.
Long-term Benefits of Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus on Right Ventricular Function Brent Keeling MD 1, Bradley G. Leshnower.
Ventricular Assist Devices A Ventricular assist device, or VAD, is a mechanical circulatory device that is used to partially or completely replace the.
1 Thoracic Organ Transplantation Committee Fall 2015.
Pediatric Mechanical Circulatory Support (MCS) Ivan Wilmot, MD Heart Failure, Transplant, MCS Assistant Professor The Heart Institute Cincinnati Children’s.
Acute Venous Pulmonary Embolism Restore cardiopulmonary hemodynamics Avoid recurrence Avoid chronic thromboembolic pulmonary hypertension Restore cardiopulmonary.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
1 National Webinar: Proposed Modification of the Adult Heart Allocation System Thoracic Organ Transplantation Committee February 2, 2016 If you are logged.
 Estimates suggest that the incidence of congenital heart disease is about 7 to 10 per 1000 live births, with moderate to severe forms afflicting 3 per.
James S. Tweddell, MD Warren W. Bailey Endowed Chair,
Society of Thoracic Surgeons 53rd Annual Meeting
Angela Lorts MD Cincinnati Children’s Hospital Medical Center
Total Artificial Heart (TAH): Survival Outcomes, Risk Factors,
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Preoperative screening for LVAD an TAH implantation
Intermacs and the Scientific Registry of Transplant Recipients (SRTR)
Mechanical circulatory support
Morning Report Anne Lachiewicz April 5, 2010.
ANZ Fontan registry Tom Gentles Paediatric Cardiologist
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
Circulatory System.
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data  Deborah Morley, PhD, Kenneth.
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Durable Mechanical Circulatory Support in Advanced Heart Failure
BVS5000 support after cardiac transplantation
Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,
Bidirectional Glenn shunt in association with congenital heart repairs: the 112 ventricular repair  Constantine Mavroudis, MD, Carl L Backer, MD, Lisa.
Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience  Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.
Pulmonary Blood Flow Patterns in Patients With Fontan Circulation
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011  William L.
Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure  Erin M. Schumer,
Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.
Fontan circulation. a) Modified atriopulmonary connection Fontan in which the systemic venous atrium is directly connected to the pulmonary arteries; b)
Conceptual model of the ageing Fontan circulation
Cardiovascular System
Constantine Mavroudis, MD, Carl L. Backer, MD, Barbara J
Presentation transcript:

RDB Jaquiss Duke University Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University

Disclosures None

Current Paradigm for Palliation Stage I – shunt/band PROTECT PVR Stage II – superior CPC RELIEVE VOLUME LOAD Stage III – Fontan completion RELIEVE CYANOSIS If (when?) palliation fails - transplant

Normal  (A) The normal cardiovascular circulation. The pulmonary circulation (P) is connected in series with the systemic circulation (S). The right ventricle maintains the right atrial pressure lower than the left atrial pressure, and provides enough energy to the blood to pass the pulmonary resistance. (B) The patient with a univentricular heart. The systemic and pulmonary circuits are connected in parallel, with a considerable volume overload to the single ventricle (V). The width of the line reflects the degree of volume load. There is complete admixture of systemic and pulmonary venous blood, causing arterial oxygen desaturation. (C) The Fontan circulation. The systemic and pulmonary circulations are connected in series. The right atrium (RA) or systemic veins are connected to the pulmonary artery (PA). The volume overload to the single ventricle is now less than expected for body surface area. In the absence of fenestration, there is no more admixture of systemic and pulmonary venous blood, but the systemic venous pressure is notably elevated. Ao; aorta; LA, left atrium; LV, left ventricle, RV, right ventricle.

Single Ventricle  (A) The normal cardiovascular circulation. The pulmonary circulation (P) is connected in series with the systemic circulation (S). The right ventricle maintains the right atrial pressure lower than the left atrial pressure, and provides enough energy to the blood to pass the pulmonary resistance. (B) The patient with a univentricular heart. The systemic and pulmonary circuits are connected in parallel, with a considerable volume overload to the single ventricle (V). The width of the line reflects the degree of volume load. There is complete admixture of systemic and pulmonary venous blood, causing arterial oxygen desaturation. (C) The Fontan circulation. The systemic and pulmonary circulations are connected in series. The right atrium (RA) or systemic veins are connected to the pulmonary artery (PA). The volume overload to the single ventricle is now less than expected for body surface area. In the absence of fenestration, there is no more admixture of systemic and pulmonary venous blood, but the systemic venous pressure is notably elevated. Ao; aorta; LA, left atrium; LV, left ventricle, RV, right ventricle.

Fontan Circulation  (A) The normal cardiovascular circulation. The pulmonary circulation (P) is connected in series with the systemic circulation (S). The right ventricle maintains the right atrial pressure lower than the left atrial pressure, and provides enough energy to the blood to pass the pulmonary resistance. (B) The patient with a univentricular heart. The systemic and pulmonary circuits are connected in parallel, with a considerable volume overload to the single ventricle (V). The width of the line reflects the degree of volume load. There is complete admixture of systemic and pulmonary venous blood, causing arterial oxygen desaturation. (C) The Fontan circulation. The systemic and pulmonary circulations are connected in series. The right atrium (RA) or systemic veins are connected to the pulmonary artery (PA). The volume overload to the single ventricle is now less than expected for body surface area. In the absence of fenestration, there is no more admixture of systemic and pulmonary venous blood, but the systemic venous pressure is notably elevated. Ao; aorta; LA, left atrium; LV, left ventricle, RV, right ventricle.

Fontan Circulation  (A) The normal cardiovascular circulation. The pulmonary circulation (P) is connected in series with the systemic circulation (S). The right ventricle maintains the right atrial pressure lower than the left atrial pressure, and provides enough energy to the blood to pass the pulmonary resistance. (B) The patient with a univentricular heart. The systemic and pulmonary circuits are connected in parallel, with a considerable volume overload to the single ventricle (V). The width of the line reflects the degree of volume load. There is complete admixture of systemic and pulmonary venous blood, causing arterial oxygen desaturation. (C) The Fontan circulation. The systemic and pulmonary circulations are connected in series. The right atrium (RA) or systemic veins are connected to the pulmonary artery (PA). The volume overload to the single ventricle is now less than expected for body surface area. In the absence of fenestration, there is no more admixture of systemic and pulmonary venous blood, but the systemic venous pressure is notably elevated. Ao; aorta; LA, left atrium; LV, left ventricle, RV, right ventricle.

How Well and How Long Does It Work? Conditional Freedom from Death or Transplant 5 years 94% 10 years 90% 15 years 87% 20 years 83%

A Very Large and Excellent Experience Conditional Survival Atriopulmonary 25 years 76% Lateral Tunnel 20 years 90% Extracardiac 13 years 97% 2

A Closer Look Survival Isn’t Everything

Problems with Fontan Circulation Low Cardiac Output (70% of Normal at Rest) Impaired Exercise Capacity pre-load (PVR) determined Thromboembolism Arrythmias Hepatopathy Nephropathy Death

Developments in Fontan Surgery Description by Fontan and Baudet Ten Commandments Lateral Tunnel Extracardiac Staging Fenestration Fontan conversion Intra/Extra “Y” Grafts

(A) The normal cardiovascular circulation  (A) The normal cardiovascular circulation. The pulmonary circulation (P) is connected in series with the systemic circulation (S). The right ventricle maintains the right atrial pressure lower than the left atrial pressure, and provides enough energy to the blood to pass the pulmonary resistance. (B) The patient with a univentricular heart. The systemic and pulmonary circuits are connected in parallel, with a considerable volume overload to the single ventricle (V). The width of the line reflects the degree of volume load. There is complete admixture of systemic and pulmonary venous blood, causing arterial oxygen desaturation. (C) The Fontan circulation. The systemic and pulmonary circulations are connected in series. The right atrium (RA) or systemic veins are connected to the pulmonary artery (PA). The volume overload to the single ventricle is now less than expected for body surface area. In the absence of fenestration, there is no more admixture of systemic and pulmonary venous blood, but the systemic venous pressure is notably elevated. Ao; aorta; LA, left atrium; LV, left ventricle, RV, right ventricle. Marc Gewillig Heart 2005;91:839-846

“…pattern of endothelial dysfunction-induced remodeling due to chronic, non-pulsatile flow with in situ thrombotic lesions.”

Fontan Circulation  (A) The normal cardiovascular circulation. The pulmonary circulation (P) is connected in series with the systemic circulation (S). The right ventricle maintains the right atrial pressure lower than the left atrial pressure, and provides enough energy to the blood to pass the pulmonary resistance. (B) The patient with a univentricular heart. The systemic and pulmonary circuits are connected in parallel, with a considerable volume overload to the single ventricle (V). The width of the line reflects the degree of volume load. There is complete admixture of systemic and pulmonary venous blood, causing arterial oxygen desaturation. (C) The Fontan circulation. The systemic and pulmonary circulations are connected in series. The right atrium (RA) or systemic veins are connected to the pulmonary artery (PA). The volume overload to the single ventricle is now less than expected for body surface area. In the absence of fenestration, there is no more admixture of systemic and pulmonary venous blood, but the systemic venous pressure is notably elevated. Ao; aorta; LA, left atrium; LV, left ventricle, RV, right ventricle.

Modes of Fontan Failure Pump failure (LV<RV) Intrinsic, iatrogenic, arrythmic, valvular Concept failure “high”PVR leading to high Fontan pressure PLE, plastic bronchitis Cyanosis (V-V collaterals)

Scope of Problem STS Congenital Database 7/2010 to 6/2014 3245 “Fontan” operation (excluding conversions) 810/year entering pipeline Scientific Registry of Transplant Recipients

Total Heart Transplants – U.S.

47% of patients were listed as Status 2 (i.e. high PVR failure) Status 2 – 10% waitlist mortality Status 1 (inotropes) – 40% waitlist mortality Status 1 (ventilator) – 70% waitlist mortality

Changing Profile of Adult Heart Transplant 2002 and 2012 % Urgency Status 1A 660 34.8 1190 58.5 1B 723 38.2 743 36.5 2 509 26.9 102 5.0 Bridge No VAD 1454 76.8 1194 58.7 VAD 440 23.2 841 41.3

Application of LVAD Pump failure (LV<RV) Concept failure Intrinsic, iatrogenic, arrythmic, valvular Concept failure “high”PVR leading to high Fontan pressure PLE, plastic bronchitis Cyanosis (V-V collaterals)

“As many as two thirds of adult Fontan patients who die or require transplantation do so with preserved ventricular function.”

LVAD for Concept Failure – “Pulling”

Concept Failure – “Pushing” “Fontan patients are doomed to a circulatory failure and many of them will require a circulatory assistance as a bridge to transplantation.”

RVAD vs. LVAD Pushing vs. Pulling Power Requirements X 0.25 X Size Small Smaller Embolic Consequences Very Bad Bad Duarbility Unknown Unknown+++

Fig. 2 Aortic flow and superior vena cava (SVC) pressure at various phases of the experiment (mean flow and pressure of all 4 animals). Aortic flow decreased with institution of the Fontan circulation and was restored upon activation of the VAD. SVC pressu...

Factors Which Will Impact Future

Right Heart Failure after LVAD ~10-15% temporary RVAD ~20-30% moderate RVF Worse survival DT Worse outcome BTT Worse QOL

“It's tough to make predictions, especially about the future.” Yogi Berra

Transplant vs. Fontan-RVAD Resting Cardiac Output Normal Exercise Cardiac Output Hepatic Venous Pressure Normal to Slightly Elevated Chronic Anticoagulation No Yes Power Cord Probably Immunosuppression Risks Diabetes, Hypertension, Renal Failure Additional Surgery Needed Yes (Redo Tx) Yes (Redo VAD or Tx)

Future Paradigm for Palliation Stage I – shunt/band PROTECT PVR Stage II – superior CPC RELIEVE VOLUME LOAD Stage III – Fontan completion RELIEVE CYANOSIS SET UP STAGE IV Stage IV A. Pump Failure leads to transplant B. Concept Failure leads to RVAD (timing?)